Canakinumab for systemic-onset juvenile idiopathic arthritis/Still's disease-effectiveness and safety data from the BiKeR registry.

Horneff G, Kallinich T, Minden K, Dressler F, Hufnagel M, Weller-Heinemann F, Klein A

Open source

DOI
10.1016/j.ero.2025.11.010
Published
2026 Jun
Container
EULAR rheumatology open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ero.2025.11.010,
  title = {Canakinumab for systemic-onset juvenile idiopathic arthritis/Still's disease-effectiveness and safety data from the BiKeR registry.},
  author = {Horneff G and Kallinich T and Minden K and Dressler F and Hufnagel M and Weller-Heinemann F and Klein A},
  year = {2026},
  journal = {EULAR rheumatology open},
  doi = {10.1016/j.ero.2025.11.010},
  url = {https://doi.org/10.1016/j.ero.2025.11.010}
}

RIS

TY  - JOUR
TI  - Canakinumab for systemic-onset juvenile idiopathic arthritis/Still's disease-effectiveness and safety data from the BiKeR registry.
AU  - Horneff G
AU  - Kallinich T
AU  - Minden K
AU  - Dressler F
AU  - Hufnagel M
AU  - Weller-Heinemann F
AU  - Klein A
PY  - 2026
JO  - EULAR rheumatology open
DO  - 10.1016/j.ero.2025.11.010
UR  - https://doi.org/10.1016/j.ero.2025.11.010
ER  - 

APA

G, H., T, K., K, M., F, D., M, H., F, W., & A, K. (2026). Canakinumab for systemic-onset juvenile idiopathic arthritis/Still's disease-effectiveness and safety data from the BiKeR registry.. EULAR rheumatology open. https://doi.org/10.1016/j.ero.2025.11.010

Source records